Actavis Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACTAVIS, and what generic and branded alternatives to ACTAVIS drugs are available?
ACTAVIS has three hundred and twenty-two approved drugs.
There are twenty tentative approvals on ACTAVIS drugs.
Summary for Actavis
| US Patents: | 0 |
| Tradenames: | 226 |
| Ingredients: | 215 |
| NDAs: | 322 |
| Patent Litigation for Actavis: | See patent lawsuits for Actavis |
| PTAB Cases with Actavis as petitioner: | See PTAB cases with Actavis as petitioner |
Drugs and US Patents for Actavis
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Mid Atlantic | CLOBETASOL PROPIONATE | clobetasol propionate | LOTION;TOPICAL | 078223-001 | Dec 4, 2008 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Actavis Group | HALOPERIDOL | haloperidol | TABLET;ORAL | 200854-006 | Jul 1, 2022 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Actavis Labs Ut Inc | ADAPALENE AND BENZOYL PEROXIDE | adapalene; benzoyl peroxide | GEL;TOPICAL | 209641-001 | Jun 22, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Actavis Totowa | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 078803-002 | Aug 8, 2012 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Actavis Labs Fl Inc | ALPRAZOLAM | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 077198-004 | May 13, 2010 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Actavis Elizabeth | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | TABLET;ORAL | 201951-001 | Jul 26, 2013 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Actavis
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Actavis Labs Ut Inc | LOXITANE IM | loxapine hydrochloride | INJECTABLE;INJECTION | 018039-001 | Approved Prior to Jan 1, 1982 | 3,546,226 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ACTAVIS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
